Prolactin-inducible protein (PIP), also known as gross cystic disease fluid protein 15 (GCDFP-15), has emerged as a subject of significant interest in recent years due to its potential role as a specific marker in breast cancer. This evidence concerns the gene PIP and breast carcinoma.